Online inquiry

IVTScrip™ mRNA-Human ARPC5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28671MR)

This product GTTS-WK28671MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARPC5 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001270439.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10092
UniProt ID O15511
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARPC5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28671MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK7744MR IVTScrip™ mRNA-Human ADGRG6, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADGRG6
GTTS-WK20362MR IVTScrip™ mRNA-Human ANXA4, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANXA4
GTTS-WK10434MR IVTScrip™ mRNA-Human ADGRD1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADGRD1
GTTS-WK27964MR IVTScrip™ mRNA-Human ARF3, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARF3
GTTS-WK15812MR IVTScrip™ mRNA-Human ANKRD26P3, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD26P3
GTTS-WK28271MR IVTScrip™ mRNA-Human ARFGAP3, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARFGAP3
GTTS-WK10495MR IVTScrip™ mRNA-Human AGC1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AGC1
GTTS-WK28691MR IVTScrip™ mRNA-Human ASAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ASAP1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →